Latest News for: NTM

Edit

Request to supplement the Agenda of the Ordinary Shareholders' meeting on 28 February 2025 (Fine Foods & Pharmaceuticals NTM SpA)

Public Technologies 06 Feb 2025
). REQUEST TO SUPPLEMENT THE AGENDA OF THE ORDINARY. SHAREHOLDERS' MEETING ON 28 FEBRUARY 2025. Verdellino (Bergamo, Italy), 6 February 2025 - Fine Foods & Pharmaceuticals N.T.M. S.p.A ... 58/1998 ... *** ... *** ... *** ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit

NOTICE OF 28 FEBRUARY 2025 SHAREHOLDERS' MEETING ADDITIONAL DOCUMENTATION FILING (Fine Foods & Pharmaceuticals NTM SpA)

Public Technologies 29 Jan 2025
). NOTICE OF 28 FEBRUARY 2025 SHAREHOLDERS' MEETING. ADDITIONAL DOCUMENTATION FILING. Verdellino (BG), 29 January 2025. Fine Foods & Pharmaceuticals N.T.M. S.p.A ... at www.1info.it. *** ... *** ... *** ... S.p.A ... S.p.A ... T ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit

9M 2024 Results Presentation (Fine Foods & Pharmaceuticals NTM SpA)

Public Technologies 14 Nov 2024
). 9M 2024 RESULTS PRESENTATION. 14/11/24. FINE FOODS. 9M 2024. 3. RESULTS PRESENTATION. WE CREATE. VALUE. FINE FOODS. 9M 2024. WE CREATE VALUE. 4. RESULTS PRESENTATION. Fine Foods at a glance ... FF) ... FINE FOODS ... 9M 2024 ... 5 ... 6 ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit

Interim Financial Report as of 30 September 2024 (Fine Foods & Pharmaceuticals NTM SpA)

Public Technologies 14 Nov 2024
). Fine Foods Group - Interim Financial Report as of 30 September 2024. FINE FOODS & PHARMACEUTICALS N.T.M. S.p.A. Registered office. VIA BERLINO 39 VERDELLINO (BG) ... Tax code and company reference number ... 1 ... 3 ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit

Paratek Pharmaceuticals Announces Positive Top-Line Data from Phase 2b Study of Oral Omadacycline (OMC) in Nontuberculous Mycobacterial (NTM) Abscessus Pulmonary Disease (Paratek Pharmaceuticals Inc)

Public Technologies 08 Nov 2024
This is something that clinicians and patients in the NTM community should be very encouraged by." ... The primary efficacy endpoint was the response on the NTM Symptom Assessment Scale at Day 84 and was evaluated 2 different ways.
Edit

Supreme NTM - Le Pouvoir (1990 - 2016 - Maxi 45T)

Bitchute 25 Oct 2024
Go to the source via the article link to view the video or lcik the video icon ....
Edit

Bioversys Joins EU-Funded Respirintm Programme To Accelerate Development Of Its Broad-Spectrum Drug Candidates Against NTM ...

MENA FN 22 Oct 2024
(MENAFN - GlobeNewsWire - Nasdaq) BASEL, Switzerland, Oct. 22, 2024 (GLOBE NEWSWIRE) -- RespiriNTM Programme allows BioVersys' NTM project to access up to –2 million of non-dilutive funding ... .
Edit

Storykit automates video production for 320 reporters at media group NTM: 'This is a real bullseye.'

The Kane Republican 09 Oct 2024
Enabling 320 reporters to create videos by pressing a button in their publishing tool. This breakthrough is the result of the Swedish local media group NTM teaming up with Storykit to automate their video processes ....
Edit

Half-Year Financial Report as of 30 June 2024 (Fine Foods & Pharmaceuticals NTM SpA)

Public Technologies 25 Sep 2024
). Fine Foods Group - 30 June 2024 Half-year Financial Report. FINE FOODS & PHARMACEUTICALS N.T.M. S.p.A. Registered office. VIA BERLINO 39 VERDELLINO (BG). Registered in the BERGAMO Companies Register ... 454184 ... Fine Foods & Pharmaceuticals NTM S.p.A.
Edit

NTM’s “fight and unite” project boosts new mobile front page with higher news density (INMA - International Newsmedia Marketing Association)

Public Technologies 17 Sep 2024
) By Jens Pettersson Head of Editorial Development NTM Stockholm, Sweden Connect Journalism is at the core of our local news business ... [...] ... Disclaimer ... (noodl. 119826679) .
Edit

H1 2024 Results Presentation (Fine Foods & Pharmaceuticals NTM SpA)

Public Technologies 13 Sep 2024
). H1 2024. RESULTS PRESENTATION. 13/09/24. FINE FOODS. H1 2024. 3. RESULTS PRESENTATION. WE CREATE. VALUE. FINE FOODS. H1 2024. WE CREATE VALUE. 4. RESULTS PRESENTATION.  .  .  .   ... FF) ... 5 ... Fine Foods & Pharmaceuticals NTM S.p.A.

Most Viewed

×